Inventories |
6 Months Ended | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Mar. 31, 2025 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Disclosure Of Inventories [Abstract] | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Inventories | 8. INVENTORIES
During the three and six months ended March 31, 2025, inventories of €163.2 million and €231.2 million, respectively, were recognized as an expense in Cost of sales. During the three and six months ended March 31, 2024, €126.4 million and €181.3 million, respectively, were recognized as an expense in Cost of sales.
As part of the Cost of sales, write-downs of inventories during the three and six months ended March 31, 2025 amounted to €5.8 million and €8.8 million, respectively. During the three and six months ended March 31, 2024, write-downs of inventories amounted to €2.9 million and €5.6 million, respectively. |
||||||||||||||||||||||||||||||||||||||||||||||||||||||